about
Lipoprotein(a) in cardiovascular diseasesEvaluation of the Hypoglycemic Properties of Anacardium humile Aqueous ExtractRelation of Apo(a) size to carotid atherosclerosis in an elderly multiethnic populationStatins and renal function.Lipoprotein (a) and other Lipid Profile in Patients with Thrombotic Stroke: Is it a Reliable Marker?Correlative study between neuron-specific enolase and blood sugar level in ischemic stroke patientsApolipoprotein E polymorphism and atherosclerosis.Lipoprotein(a): an emerging cardiovascular risk factor.The increasing impact of laboratory medicine on clinical cardiology.Lipoprotein (a) does not participate in the early acute phase response to training or extreme physical activity and is unlikely to enhance any associated immediate cardiovascular risk.Prevention and treatment of the metabolic syndrome.Biomarkers of Alzheimer disease in plasmaEffects of oestrogen receptor-active compounds on lipid metabolism.Secondary prevention of ischemic cerebrovascular disease. What is the evidence?Non-low-density lipoprotein cholesterol-associated actions of ezetimibe: an overview.The role of established and emerging risk factors in peripheral vascular graft occlusion.Vascular risk factors, cognitive decline, and dementiaCardiovascular biomarkers: increasing impact of laboratory medicine in cardiology practice.Stroke in systemic lupus erythematosus.Eicosanoids and their drugs in cardiovascular diseases: focus on atherosclerosis and stroke.Atherosclerosis, biomarkers of atherosclerosis and Alzheimer's disease.Effect of fenofibrate on serum inflammatory markers in patients with high triglyceride values.Risk factors for cryptogenic ischaemic stroke.Lipoprotein(a) and abdominal aortic aneurysm risk: The Atherosclerosis Risk in Communities study.Fractions of total plasma homocysteine in patients with ischemic stroke before the age of 55 years.The relationship between serum lipoprotein (a) levels and ischemic stroke risk: a cohort study in the Chinese population.
P2860
Q21284797-36213908-E114-4E0F-83E3-5AC3DCAC23E7Q21285110-556E3161-D003-469B-B7CB-18C81CB6F682Q28344927-98EEEA86-3E4B-417D-B8EB-33128176F24BQ34940824-1EFB1530-E894-45C6-AA90-F325FADBE097Q35053791-171F2DBF-8771-472A-9D4F-8947BF1F0557Q35067529-0EC1F310-4A10-4BCB-8E64-49214B5492AAQ35068761-CC276A84-D6AE-4863-B5C7-A0C419DC5A5EQ35081894-E71681FD-5DF7-4070-99A0-CC4BD366A1B1Q35206514-37E98E6F-F8A9-47E9-9FC1-1EA852A32594Q35586112-B3042746-96F5-46FD-AB1D-2290956C94E7Q35952447-CE5969B4-F1E1-4C22-9717-4CB3ED42CB0FQ36045288-8C13E523-9384-408A-9ED8-AEEAB7E35D19Q36210997-393E2036-CEDD-4224-9FCD-39D5E7C6C279Q36271814-AAAEB0A2-E73E-43FC-A81A-B977814B1ABCQ36653658-B2878F71-217E-4151-997D-DE5DA85665AAQ36808026-8B14E1C6-7EAB-4D10-9DB0-E5DDBEEF55EDQ36812802-7E4653D4-9E41-4C4D-ADD0-D7BBBD6DFC55Q37207281-17D9EE5C-1F21-467A-BC61-A20017B6FCF9Q37610182-456AD2C3-3309-4ABA-8CE5-CC115ED9644CQ37995534-AC8C0E3A-B762-4899-B38B-A7A34E338DADQ38119019-4D7BCF3F-22A0-4E55-990F-72E132E26891Q40516350-E0C281D2-03D1-49BA-A633-127153931BF7Q44230227-FF5BC025-4578-47A7-BA82-3BE9AA95A7E6Q46289476-9F8627DF-5A43-4800-B6A7-F8749D380B2DQ46406762-7D7EFB88-7732-4CEC-8FB2-7A68DC138469Q48831348-3287A73F-5411-492F-A3B1-415D74F2A603
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Lipoprotein (a) and stroke
@ast
Lipoprotein (a) and stroke
@en
type
label
Lipoprotein (a) and stroke
@ast
Lipoprotein (a) and stroke
@en
prefLabel
Lipoprotein (a) and stroke
@ast
Lipoprotein (a) and stroke
@en
P2093
P2860
P356
P1476
Lipoprotein (a) and stroke
@en
P2093
Mikhailidis DP
Milionis HJ
P2860
P304
P356
10.1136/JCP.53.7.487
P407
P577
2000-07-01T00:00:00Z